Skip to main content

Unfortunately we don't fully support your browser. If you have the option to, please upgrade to a newer version or use Mozilla Firefox, Microsoft Edge, Google Chrome, or Safari 14 or newer. If you are unable to, and need support, please send us your feedback.

Publish with us

Embase content is updated daily and expanding globally

Embase provides unparalleled coverage of the medical literature, including information not available in MEDLINE. Regulatory bodies recommend Embase as a source for comprehensive systematic literature reviews.

By the numbers: current Embase coverage

Embase journal coverage is from 1947 on with historical records included in Embase Classic.

  • 45.6 million records, an average of 8,535 new entries daily and over 12 million records not in MEDLINE

  • 3,365 journals unique to Embase and 8,451 currently published journals, including MEDLINE titles

  • 5.1 million conference abstracts from 15,577 conferences

  • 99,730 preferred terms in Emtree with 525,755 synonyms, 64 drug subheadings, 14 disease subheadings, 4 device subheadings

  • 95 countries represented in journal selection. Local literature modules available as add-on

Download a list of journalsopens in new tab/window currently covered in Embase.

Download a list of the conferencesopens in new tab/window currently covered in Embase.

Ready to take the next step?


Local literature modules in Embase

Embase has a French Local Literature Module. It enables users to monitor French-language journals for adverse drug reactions and helps you comply with EMA requirements.

  • More than 100 relevant journals identified based on input from industrial partners, the EMA and ANSM

  • Full-text articles translated using human-aided machine translation with human quality control

  • Translated full-text articles are manually indexed using Emtree

Embase data for applied analytics

Embase content is available as enriched, machine-readable data. It can be licensed off platform to:

  • Enrich content via semantic tagging for machine readability

  • Organize and connect content to reveal concepts and relationships

  • Enhance KOL databases for internal use

  • Combine Embase data with other data sources for: - Competitive intelligence dashboards - Regulatory and medical affairs insights - Market access analysis and positioning

We offer flexible data packages, supported by a team of data experts, to help your projects succeed. Combine and text mine internal and external datasets to aid insight and discovery across medical affairs, regulatory, and drug discovery. Embase data includes drug and device names, synonyms and relevant terms:

  • Generic drug names from the FDA/EMA

  • International nonproprietary names (INNs) for drugs

  • Drug trade names

  • Diseases, organisms, biological functions, medical and biological parameters

  • Global medical device nomenclature (GMDN) used by the FDA

Contact us to discuss how Embase data can enhance your scientific intelligence, risk monitoring, and development and payer strategy.